Cocrystal Pharma, Inc. — Director's Dealing 2015

Mar 25, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2015-03-23

Reporting Person: Meckler Jeffrey A (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-23	Stock Option (Right to Buy)	$1.015	A	1750000	Acquired	2025-03-23	Common Stock (1750000)	Direct

Footnotes

F1: The securities vest monthly over a period of six months in six approximately equal increments beginning on April 23, 2015, subject to continued employment on each applicable vesting date.

F2: Not applicable.